Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Joel Brothers"'
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground: T-prolymphocytic leukemia (T-PLL) is an aggressive hematologic malignancy. A portion of patients can be cured with alemtuzumab induction followed by allogeneic hematopoietic stem cell transplant, but patients who relapse after tra
Externí odkaz:
https://doaj.org/article/2fab398806a24985a9f7976cb6305edf
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Undifferentiated pleomorphic sarcoma (UPS), a subtype of soft tissue sarcoma (STS), is an uncommon malignancy associated with a poor prognosis. As with other forms of sarcoma, surgical resection remains the only form of treatment with curative potent
Externí odkaz:
https://doaj.org/article/09198af9a5424caf86f0ffb853df6fee
Autor:
Won Jin Jeon, Jasmine Nguyen, Dani Ran Castillo, Kiwon Park, Joel Brothers, Anthony Nguyen, Hamid Mirshahidi
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211509
Introduction Pembrolizumab (Keytruda) is a monoclonal antibody against the programmed cell death-1 (PD-1) receptor on lymphocytes, which is one of the immune checkpoint inhibitors (ICIs) approved for multiple solid and hematologic malignancies. Altho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41e73720c40064be43c1d89988d911f5
https://doi.org/10.1177/10781552221150936
https://doi.org/10.1177/10781552221150936
Autor:
Brothers, Joel1 (AUTHOR) jbrothers@llu.edu, Castillo, Dan Ran1 (AUTHOR), Jeon, Won Jin1 (AUTHOR), Joung, Bowon1 (AUTHOR), Linhares, Yuliya2 (AUTHOR)
Publikováno v:
Hematology. Dec2023, Vol. 28 Issue 1, p1-4. 4p.
Autor:
Castillo, Dani Ran1 (AUTHOR) drcastillo@llu.edu, Park, Daniel2 (AUTHOR), Jeon, Won Jin3 (AUTHOR), Joung, Bowon3 (AUTHOR), Lee, Jae4 (AUTHOR), Yang, Chieh5 (AUTHOR), Pham, Bryan3 (AUTHOR), Hino, Christopher3 (AUTHOR), Chong, Esther1 (AUTHOR), Shields, Andrea6 (AUTHOR), Nguyen, Anthony7 (AUTHOR), Brothers, Joel1 (AUTHOR), Liu, Yan6 (AUTHOR), Zhang, Ke K.7,8 (AUTHOR) kzhang@tamu.edu, Cao, Huynh1 (AUTHOR) kzhang@tamu.edu
Publikováno v:
International Journal of Molecular Sciences. Jun2023, Vol. 24 Issue 12, p10207. 12p.
Autor:
Hino, Christopher, Lacy, Curtis, Brothers, Joel, Cao, Huynh, Mirshahidi, Hamid, Park, Kiwon, Akhtari, Mojtaba
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; Oct2023, Vol. 23 Issue 10, p764-771, 8p
Autor:
Jeon, Won Jin, Nguyen, Jasmine, Castillo, Dani Ran, Park, Kiwon, Brothers, Joel, Nguyen, Anthony, Mirshahidi, Hamid
Publikováno v:
Journal of Oncology Pharmacy Practice; Jul2023, Vol. 29 Issue 5, p1264-1267, 4p
Autor:
Jooste, Graham farmersweekly@caxton.co.za
Publikováno v:
Farmer's Weekly. 11/24/2023, p66-67. 2p.
Autor:
Siva, Amara C.1 asiva@genoptix.com, Nelson, Luke J.1 LukeN@gen-probe.com, Fleischer, Chad L.1 ChadF@gen-probe.com, Majlessi, Mehrdad1 MehrdadM@gen-probe.com, Becker, Michael M.1 MickB@gen-probe.com, Vessella, Robert L.2,3 vessella@u.washington.edu, Reynolds, Mark A.1 MarkR@gen-probe.com
Publikováno v:
Molecular Cancer. 2009, Vol. 8, Special section p1-12. 12p. 1 Diagram, 4 Graphs.
Publikováno v:
Hematology Week; 12/22/2023, p424-424, 1p